Gameto

Gameto Raises $23 Million to Redefine Reproductive Longevity With Reprogrammed Ovarian Cells

PRESS RELEASE — Gameto, a biotechnology start-up solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, announced that it has raised a $20 million in Series A funding. With some of the initial research conducted at the George Church lab at¬†Harvard Medical School, Gameto has achieved ground-breaking results …

Gameto Raises $23 Million to Redefine Reproductive Longevity With Reprogrammed Ovarian Cells Read More »